CEO of Oncolytics Biotech talks about Cancer Research

April 9, 2015 2:45 PM

3 0

CEO of Oncolytics Biotech talks about Cancer Research

Brad Thompson, CEO of Oncolytics Biotech, said it was really exciting for him to see CBS'60 Minutes drawing attention to virus-based cancer treatments a couple weeks back. However, he said that there is a lot more involved when it's about treating a disease.

The episode surrounded an engineered polio virus being developed at Duke University to treat glioblastoma, a deadly form of brain cancer. Thompson's company was founded in 1998 on discoveries made at the University of Calgary about the cancer-killing prowess of reovirus.

Read more

To category page

Loading...